Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
665.00    0.00 (0.00%)
Bid:
664.00
Ask:
667.00
Spread: 3.00 (0.452%)
Market Cap: £541.28m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Acquisition

2 Jun 2021 12:17

RNS Number : 6090A
Bloomsbury Publishing PLC
02 June 2021
 

BLOOMSBURY PUBLISHING PLC

("Bloomsbury" or "the Company")

Bloomsbury acquisition strengthens Consumer division: Acquisition of Head of Zeus Limited

 2 June 2021

Bloomsbury Publishing Plc (LSE: BMY), the leading independent publisher, today announces that it has completed the acquisition of the issued share capital of Head of Zeus Limited ("Head of Zeus", "HoZ" or the "Acquisition"). The total valuation is £8.45 million, including payments of pre-existing loans. The consideration, net of pre-existing loans, is £7.35 million, of which £5.5 million will be satisfied in cash at completion, with £1.1 million payable in cash post completion, subject to working capital and other considerations, and £0.75 million of deferred consideration payable in cash subject to achievement of revenue, profit and Netflix release targets.

Head of Zeus is an independent publisher of genre fiction and narrative non-fiction and children's books, based in London. It has published many bestsellers, won literary prizes and industry awards. Its best-selling authors include Dan Jones, Cixin Liu, Victoria Hislop, and Lesley Thomson, and Elodie Harper, whose The Wolf Den went last week to number 5 in The Times bestseller list. Cixin Liu's bestselling science fiction trilogy, The Three-Body Problem, is being adapted for Netflix by David Benioff and D.B. Weiss, creators of HBO's Game of Thrones.

This acquisition will provide a strong addition to Bloomsbury's thriving Consumer division and support our long term Consumer growth strategy, with new high quality authors and effective publishing across all formats, including e-book and audio.

HoZ generated £8.6 million* of revenue in the year ended 31 December 2020, and profit before tax of £0.3 million*, with net assets of £4.6 million*.

Nigel Newton, Chief Executive of Bloomsbury, commented:

"Head of Zeus's entrepreneurial and innovative approach to publishing, and its wide range of trade titles, will make a strong addition to Bloomsbury's own. Bloomsbury will be able to provide the scale and digital platforms to boost Head of Zeus' success while operating as an independent imprint within the Bloomsbury Consumer division. We look forward to welcoming Head of Zeus' great authors and talented staff to Bloomsbury and working with them in the years to come."

Anthony Cheetham, Chairman, Head of Zeus commented:

"After nine vigorous years as an independent publisher, I believe that Head of Zeus, our authors, our staff and our shareholders have found the right long term home for our company with Bloomsbury.

I have known Nigel Newton for more than thirty years. We share many of the same values: creative publishing, unique content and beautiful books. And an entrepreneurial spirit that values innovation above conformity. Bloomsbury Publishing Plc is itself unique as the only British book publisher listed on the London Stock Exchange.

I would like to express my gratitude to all our stakeholders for their support since Head of Zeus was launched in 2012, and my thanks to Bloomsbury for opening the door to further growth and opportunity in the years ahead."

*Audited.

 

For further information, please contact:

Bloomsbury Publishing Plc

 

Nigel Newton, Chief Executive

nigel.newton@bloomsbury.com

Penny Scott-Bayfield, Group Finance Director

penny.scott-bayfield@bloomsbury.com

Hudson Sandler

+44 (0) 20 7796 4133

Dan de Belder / Rebekah Chapman

bloomsbury@hudsonsandler.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.

Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward‑looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.

The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward‑looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.

References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUUAARAOUNRAR
Date   Source Headline
13th Aug 20215:49 pmRNSDirector/PDMR Shareholdings - Correction
10th Aug 20213:07 pmRNSDirector/PDMR Shareholdings
3rd Aug 20211:15 pmRNSDirector/PDMR Shareholding
21st Jul 20214:52 pmRNSResults of the 2021 Annual General Meeting
21st Jul 20217:00 amRNSAGM Trading Update
15th Jul 20213:31 pmRNSAnnual General Meeting
22nd Jun 20214:09 pmRNSAnnual Financial Report
11th Jun 20214:00 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSInvestor Results Presentation
3rd Jun 202111:46 amRNSHolding(s) in Company
2nd Jun 202112:17 pmRNSAcquisition
2nd Jun 20217:00 amRNSAudited Preliminary Results
1st Jun 20217:00 amRNSCompletion of Acquisition
5th May 20219:00 amRNSNotice of Results
23rd Apr 20217:00 amRNSAcquisition
8th Apr 20214:35 pmRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSFurther Trading Update
10th Mar 20218:46 amRNSHolding(s) in Company
17th Feb 20214:18 pmRNSBlock Listing Six Monthly Return
29th Jan 202112:00 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSTrading Update
14th Dec 20207:00 amRNSBoard Appointment
27th Oct 20207:00 amRNSUnaudited Interim Results
13th Oct 20203:37 pmRNSHolding(s) in Company
4th Sep 202012:08 pmRNSSecond Price Monitoring Extn
4th Sep 202012:02 pmRNSPrice Monitoring Extension
28th Aug 20206:14 pmRNSDirector/PDMR Shareholding
28th Aug 20201:05 pmRNSTotal Voting Rights
25th Aug 20205:54 pmRNSFinal dividend: bonus issue of new shares
10th Aug 20205:04 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSDirector/PDMR Shareholding
31st Jul 20201:58 pmRNSFinal dividend: bonus issue of new shares
30th Jul 20205:54 pmRNSDirector/PDMR Shareholding
21st Jul 20201:00 pmRNSResults of the 2020 Annual General Meeting
21st Jul 20207:00 amRNSAGM Trading Update
8th Jul 20204:35 pmRNSAnnual General Meeting
18th Jun 20202:00 pmRNSAnnual Financial Report
17th Jun 202012:07 pmRNSSecond Price Monitoring Extn
17th Jun 202012:02 pmRNSPrice Monitoring Extension
12th Jun 20204:41 pmRNSSecond Price Monitoring Extn
12th Jun 20204:36 pmRNSPrice Monitoring Extension
3rd Jun 202012:08 pmRNSSecond Price Monitoring Extn
3rd Jun 202012:02 pmRNSPrice Monitoring Extension
26th May 20205:26 pmRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 20207:00 amRNSUnaudited Preliminary Results
28th Apr 20203:37 pmRNSDisclosure of Rights Attached to Equity Shares
24th Apr 20209:10 amRNSHolding(s) in Company
24th Apr 20209:06 amRNSHolding(s) in Company
21st Apr 20208:45 amRNSTotal Voting Rights
20th Apr 202012:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.